Skip to main content
Quest Diagnostics Home

High Levels of Myeloperoxidase are Similar Across ASCVD Risk Groups and are Associated with Markers of Liver Fibrosis and Kidney Function in a Workforce Population

AHA 2021: Scientific Sessions if the American Heart Association
Nashville, TN, November 13-15, 2021

High Levels of Myeloperoxidase are Similar Across ASCVD Risk Groups and are Associated with Markers of Liver Fibrosis and Kidney Function in a Workforce Population

Authors: Iakoubova OA, Judy Louie, Shiffman D, McPhaul MJ, Penn MS,

Specialties: Endocrinology, Cardiovascular disease

Download key summary

Our company

Locations Careers Investors Specialty labs Newsroom
Site map   •   Privacy   •   Terms   •   Cookie notice   •   Contact us   •   Language assistance / non-discrimination   •   Asistencia de idiomas / Aviso de no discriminación   •   語言協助 / 不歧視通知   •   Privacy Shield   •   DO NOT SELL MY PERSONAL INFORMATION   •   Accessibility

Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2022 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.